Aether Biomedical, a biotech company creating bionic upper-limb prosthetics, announced the conclusion of a $5.8 million Series A funding round. The new capital will enable the company to expand manufacturing options for its Zeus hand and advance research and development. Aether has committed 75 percent of its current workforce to research and development.
“I founded Aether Biomedical with a resolute commitment to make bionics accessible for all people,” said Dhruv Agrawal, CEO and cofounder. “We know that upper-limb amputees want stronger grips and less downtime if their prosthesis needs maintenance. As such, we’ve developed new cloud-based technology, akin to modern smart home devices, to increase communication between provider and patient, shortened the time of maintenance by sending parts directly to providers, and improved grip strength by 30-40 percent over other market options.”
Since its inception in 2017, Aether has created and distributed hundreds of Zeus hands. The company has distributed more than 250 of the devices this year.
